MarketInOut Stock Screener Log In | Sign Up

ADMA Biologics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 11/06/2026
ADMA Biologics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,823.23 mln
Float212 mln
Earnings Date03/25/2027

EPS

0.77
Moderate

P / E

16.53
Moderately valued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.45
Borderline

Relative Strength

96 / 100
Top performer

Debt / Equity

0.46
Low leverage

Business Description

ADMA Biologics is a U.S.-based company that produces and sells medicines made from human plasma, primarily used to help patients with weakened immune systems or serious infections like Hepatitis B. Founded in 2004 and based in Ramsey, New Jersey, the company runs its own plasma collection centers and manufacturing operations to support its product line. Its treatments reach patients through wholesalers, specialty pharmacies, and distributors across the United States and in other countries.

Key Fundamentals

EPS0.77
P/E16.53
ROE42.51
RPS2.24
ROIC37.31
ROA27.77
Interest Cover22.04
EBITDA, mln253
EV / EBITDA11.47
EV / EBIT11.82
Revenue, mln519
EV / Revenue5.58

Quote Details

Last 12.73
Change -0.48 (-3.63%)
Open 12.88
Volume 4,641,966
Turnover 59,092,224
Average Volume 3,948,819

Financial Ratios

Pre-Tax Profit Margin45
Leverage Ratio1.67
Current Ratio6.04
Price / Book6.39
Price / Tangible Book6.45
Price / Cash Flow20.23
Price / Free Cash Flow22.43
Debt / Equity0.46
Price / Sales5.67

Financial Strength

Altman Z-Score8.58
Piotroski F-Score 4 / 9
Beneish M-Score-2.45
Price to Intrinsic Value9.51
Price to Graham Number2.17
Short Ratio5.82
Short % of Float10.82

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.57% 95 / 100   
1 Month 23.23% 96 / 100   
2 Months 45.65% 98 / 100   
6 Months 55.81% 97 / 100   
1 Year -17.18% 31 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog